Abstract
Background: Botulinum neurotoxin (BoNT) is considered the first choice in cervical dystonia (CD) treatment. The injection of BoNT into the sternocleidomastoid muscle (SCM) for CD patients is one of the main causes of dysphagia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
